Robert Califf, MD
Deputy Commissioner, Medical Products and Tobacco, US FDA
Robert is Deputy Commissioner for Medical Products and Tobacco for the U.S. Food and Drug Administration (FDA). Appointed in February 2015, Robert provides executive leadership to the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Health and the Center for Tobacco Products. He also oversees the Office of Special Medical Programs and provides direction for cross-cutting clinical, scientific and regulatory initiatives, including personalized medicine, orphan drugs, pediatric science, and the advisory committee system. Prior to joining the FDA, Robert served as the Donald F. Fortin, MD, Professor of Cardiology at Duke and most recently, Vice Chancellor for Clinical and Translational Research.